147.54BMarket Cap
10.30P/E TTM
NVO Balance Sheet
You can check out the annual or quarterly balance sheets of Novo Nordisk A/S here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing NVO stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Novo Nordisk A/S Have?
In its most recent quarterly, Novo Nordisk A/S had 6.80B in cash and cash equivalents.
How Much Are Novo Nordisk A/S's Total Liabilities?
Novo Nordisk A/S reported 54.86B in total liabilities as of the latest reported quarter, including 33.92B in current liabilities and 20.95B in non-current liabilities.
What Are Novo Nordisk A/S's Total Assets?
As of the latest reported quarter, Novo Nordisk A/S's total assets were 85.38B, consisting of 27.12B in current assets and 58.26B in non-current assets.
How Much Shareholders' Equity Does Novo Nordisk A/S Have?
Novo Nordisk A/S reported 30.52B in total shareholders' equity as of the latest reported quarter.